Nifty
Sensex
:
:
10397.45
33844.86
37.05 (0.36%)
141.27 (0.42%)

Pharmaceuticals & Drugs

Rating :
23/99

BSE: 524372 | NSE: ORCHIDPHAR

16.25
0.00 (0%)
21-Feb-2018 | 3:42PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 15.60
  • 16.50
  • 15.45
  • 16.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 43534
  • 7.07
  • 39.70
  • 15.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 144.57
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,993.66
  • N/A
  • -0.55

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 26.68%
  • 16.21%
  • 51.11%
  • FII
  • DII
  • Others
  • 0.26%
  • 3.70%
  • 2.04%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Standalone Figures in Rs. Crores

Description
Sep 17
Sep 16
Var%
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Net Sales
-
796.50
873.44
1,746.61
1,947.70
1,873.60
1,781.79
2,358.76
1,296.85
1,300.96
963.82
Net Sales Growth
-
-8.81%
-49.99%
-10.32%
3.95%
5.15%
-24.46%
81.88%
-0.32%
34.98%
 
Cost Of Goods Sold
-
393.46
400.96
779.03
990.12
876.31
868.89
795.29
547.45
441.36
325.11
Gross Profit
-
403.05
472.47
967.58
957.58
997.29
912.90
1,563.47
749.40
859.61
638.71
GP Margin
-
50.60%
54.09%
55.40%
49.16%
53.23%
51.23%
66.28%
57.79%
66.08%
66.27%
Total Expenditure
-
709.37
702.65
1,429.32
1,837.44
1,516.99
1,433.68
1,500.34
1,126.28
961.02
714.90
Power & Fuel Cost
-
54.33
55.28
102.19
121.72
89.14
76.80
70.58
77.55
72.90
55.12
% Of Sales
-
6.82%
6.33%
5.85%
6.25%
4.76%
4.31%
2.99%
5.98%
5.60%
5.72%
Employee Cost
-
80.25
86.81
193.82
252.70
176.41
164.73
174.48
137.46
117.14
92.45
% Of Sales
-
10.08%
9.94%
11.10%
12.97%
9.42%
9.25%
7.40%
10.60%
9.00%
9.59%
Manufacturing Exp.
-
87.40
94.33
182.40
226.41
198.70
150.32
176.73
156.91
169.37
133.37
% Of Sales
-
10.97%
10.80%
10.44%
11.62%
10.61%
8.44%
7.49%
12.10%
13.02%
13.84%
General & Admin Exp.
-
40.99
31.10
91.62
93.40
76.95
92.71
113.80
68.19
67.89
49.51
% Of Sales
-
5.15%
3.56%
5.25%
4.80%
4.11%
5.20%
4.82%
5.26%
5.22%
5.14%
Selling & Distn. Exp.
-
45.73
27.73
51.28
55.52
63.26
55.06
44.17
50.71
50.57
39.16
% Of Sales
-
5.74%
3.17%
2.94%
2.85%
3.38%
3.09%
1.87%
3.91%
3.89%
4.06%
Miscellaneous Exp.
-
7.21
6.44
28.97
97.57
36.21
25.17
125.30
88.00
41.81
39.16
% Of Sales
-
0.91%
0.74%
1.66%
5.01%
1.93%
1.41%
5.31%
6.79%
3.21%
2.09%
EBITDA
-
87.13
170.79
317.29
110.26
356.61
348.11
858.42
170.57
339.94
248.92
EBITDA Margin
-
10.94%
19.55%
18.17%
5.66%
19.03%
19.54%
36.39%
13.15%
26.13%
25.83%
Other Income
-
19.17
24.91
42.47
40.72
56.19
53.02
8.59
86.05
71.30
28.01
Interest
-
331.11
294.24
537.12
522.69
179.75
116.75
242.27
156.45
82.00
99.29
Depreciation
-
141.02
145.27
324.58
251.92
153.74
133.50
154.90
133.99
100.68
85.09
PBT
-
-365.82
-243.82
-501.95
-623.63
79.32
150.87
469.83
-33.82
228.56
92.56
Tax
-
-48.04
-17.25
-191.46
-12.52
-22.04
15.38
130.58
15.17
53.23
14.01
Tax Rate
-
8.92%
5.82%
49.27%
2.19%
-29.22%
8.96%
27.79%
-44.86%
23.29%
15.14%
PAT
-
-490.49
-279.11
-196.51
-558.02
97.48
156.19
339.25
-48.99
175.34
78.55
PAT before Minority Interest
-
-490.49
-279.11
-197.13
-559.99
97.48
156.19
339.25
-48.99
175.34
78.55
Minority Interest
-
0.00
0.00
0.62
1.97
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
-61.58%
-31.96%
-11.25%
-28.65%
5.20%
8.77%
14.38%
-3.78%
13.48%
8.15%
PAT Growth
-
-75.73%
-42.03%
64.78%
-672.45%
-37.59%
-53.96%
792.49%
-127.94%
123.22%
 
Unadjusted EPS
-
-55.13
-32.07
-26.88
-79.21
13.84
22.17
48.16
-7.14
26.63
11.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Shareholder's Funds
-387.67
49.04
329.39
379.99
1,132.30
1,069.24
937.66
633.80
664.98
485.10
Share Capital
88.96
88.96
85.26
70.45
70.44
70.44
70.44
70.44
65.85
65.82
Total Reserves
-476.63
-39.92
244.12
309.53
1,061.86
998.80
867.22
563.36
599.13
419.28
Non-Current Liabilities
2,204.95
2,475.41
2,609.35
1,064.40
1,251.94
849.66
1,864.07
2,744.32
2,085.45
1,741.16
Secured Loans
2,156.78
2,377.54
2,493.95
901.79
1,074.15
604.06
1,035.91
1,714.11
979.56
706.56
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
625.36
901.74
990.98
942.25
Long Term Provisions
2.07
3.73
4.18
5.24
7.72
9.64
0.00
0.00
0.00
0.00
Current Liabilities
1,540.72
1,337.62
1,122.66
3,206.03
1,551.05
1,989.41
971.83
855.83
733.80
664.75
Trade Payables
424.52
374.27
311.15
597.40
447.00
335.16
318.21
390.10
296.23
234.55
Other Current Liabilities
476.24
285.34
112.64
1,052.57
406.96
1,005.23
293.78
369.16
359.23
388.52
Short Term Borrowings
599.52
633.79
646.64
1,524.89
647.06
489.86
0.00
0.00
0.00
0.00
Short Term Provisions
40.44
44.22
52.23
31.17
50.03
159.16
359.84
96.58
78.34
41.68
Total Liabilities
3,358.00
3,862.07
4,061.40
4,651.04
3,938.11
3,910.23
3,773.56
4,233.95
3,484.23
2,891.01
Net Block
1,496.54
1,636.83
1,795.20
2,583.57
2,073.88
1,741.76
1,603.31
2,007.51
1,539.95
1,105.40
Gross Block
3,005.92
3,005.87
3,002.15
3,772.17
3,089.68
2,613.62
2,344.63
2,695.66
2,098.12
1,563.38
Accumulated Depreciation
1,509.38
1,369.04
1,206.95
1,188.60
1,015.80
871.86
741.32
688.16
558.17
457.98
Non Current Assets
2,478.86
2,610.87
2,783.27
3,549.62
2,684.83
2,383.94
2,072.24
2,554.21
2,160.07
1,658.45
Capital Work in Progress
288.31
280.40
281.51
360.42
352.25
332.29
468.92
546.70
620.12
553.04
Non Current Investment
0.96
0.81
0.81
0.95
0.81
0.81
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
685.17
680.83
681.63
576.08
219.66
287.82
0.00
0.00
0.00
0.00
Other Non Current Assets
7.88
12.00
24.12
28.60
38.23
21.26
0.00
0.00
0.00
0.00
Current Assets
879.14
1,251.20
1,278.12
1,101.42
1,253.29
1,526.30
1,701.32
1,596.17
1,324.16
1,232.57
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.81
0.81
0.81
0.08
Inventories
211.25
241.85
251.93
506.24
668.73
617.63
422.64
768.25
649.15
611.61
Sundry Debtors
203.00
310.07
256.57
179.06
113.24
513.48
736.98
672.54
537.94
383.16
Cash & Bank
257.06
314.94
390.56
23.42
176.92
201.08
335.16
52.51
31.04
118.92
Other Current Assets
207.82
116.72
105.80
14.35
294.41
194.12
205.73
102.06
105.21
118.78
Short Term Loans & Adv.
198.36
267.62
273.26
378.34
278.33
184.86
201.40
96.97
101.66
115.71
Net Current Assets
-661.58
-86.42
155.46
-2,104.61
-297.76
-463.11
729.49
740.34
590.36
567.82
Total Assets
3,358.00
3,862.07
4,061.39
4,651.04
3,938.12
3,910.24
3,773.56
4,233.96
3,484.23
2,891.02

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
317.01
212.20
-369.07
168.17
737.02
332.13
-34.32
45.90
210.29
96.02
PBT
-452.28
-296.18
-243.29
-572.51
75.44
171.57
469.83
-33.82
228.56
92.56
Adjustment
582.11
490.19
1,006.39
661.19
333.54
214.51
-557.33
199.78
132.43
189.01
Changes in Working Capital
187.17
18.19
-669.27
79.49
356.82
7.24
119.07
-117.26
-118.42
-184.38
Cash after chg. in Working capital
317.01
212.20
93.84
168.17
765.80
393.31
31.57
48.71
242.57
97.18
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
-47.03
0.00
-28.78
-61.18
-65.89
-2.81
-32.28
-1.16
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
-415.87
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-8.59
-1.46
1,333.66
-986.04
-293.05
-367.41
1,412.76
-476.97
-545.40
-477.21
Net Fixed Assets
-7.97
-2.38
848.92
-751.02
-494.66
-121.72
428.65
-504.48
-594.63
-455.46
Net Investments
-0.01
0.00
-0.47
24.72
-18.48
-6.85
-1.20
-8.55
1.89
-17.47
Others
-0.61
0.92
485.21
-259.74
220.09
-238.84
985.31
36.06
47.34
-4.28
Cash from Financing Activity
-366.30
-286.36
-597.44
664.38
-480.15
-77.75
-1,076.81
431.08
247.36
485.21
Net Cash Inflow / Outflow
-57.88
-75.62
367.14
-153.49
-36.17
-113.03
301.64
0.02
-87.75
104.02
Opening Cash & Equivalents
314.94
390.56
23.42
176.92
213.09
326.13
24.49
24.47
112.22
8.20
Closing Cash & Equivalent
257.06
314.94
390.56
23.42
176.92
213.09
326.13
24.49
24.47
112.22

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Book Value (Rs.)
-43.58
5.51
38.63
53.94
160.74
151.79
133.11
78.11
100.98
73.70
ROA
-13.59%
-7.05%
-4.53%
-13.04%
2.48%
4.07%
8.47%
-1.27%
5.50%
3.10%
ROE
0.00%
-147.51%
-55.58%
-74.06%
8.86%
15.56%
45.60%
-8.06%
30.49%
12.46%
ROCE
-6.93%
-0.06%
4.17%
-1.48%
8.12%
10.03%
24.70%
4.23%
13.02%
9.70%
Fixed Asset Turnover
0.27
0.29
0.52
0.57
0.66
0.73
0.94
0.55
0.72
0.67
Receivable days
115.97
116.98
45.27
27.22
60.58
126.84
108.66
168.81
128.10
135.56
Inventory Days
102.41
101.94
78.79
109.43
124.35
105.52
91.80
197.67
175.34
196.34
Payable days
186.30
148.72
86.46
100.90
89.04
77.18
87.92
107.36
90.80
99.53
Cash Conversion Cycle
32.07
70.20
37.60
35.76
95.89
155.18
112.54
259.12
212.65
232.37
Total Debt/Equity
-8.01
65.54
9.75
8.43
1.77
1.94
1.77
4.75
2.96
3.40
Interest Cover
-0.63
-0.01
0.28
-0.10
1.42
2.47
2.94
0.78
3.79
1.93

News Update:


  • Orchid Pharma gets EIR report from USFDA for Chennai facility
    8th Jan 2018, 15:21 PM

    The facility was inspected by USFDA in the month of June 2017

    Read More
  • Serum Institute sells 7 lakh shares of Orchid Pharma
    20th Dec 2017, 09:23 AM

    It has sold 7,05,652 shares at Rs 19.37 per share on the NSE on December 19, 2017

    Read More
  • Serum Institute sells 7.5 lakh shares of Orchid Pharma
    19th Dec 2017, 09:11 AM

    It has sold the shares at Rs 18.55 per share on the NSE on December 18, 2017

    Read More
  • Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating Tablets
    13th Dec 2017, 13:32 PM

    Aripiprazole Orally-Disintegrating Tablets are atypical antipsychotic, indicated in the treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.